Spero Therapeutics, Inc.
Public company- Headquarters
- CAMBRIDGE, Massachusetts
- Ticker
- SPRO
- CIK
- 0001701108
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| COOTimothy Keutzer | Oct 27, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- ENANTA PHARMACEUTICALS INC
CEO departs: Jay R. Luly, Ph.D.
- VERTEX PHARMACEUTICALS INC / MA
new member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
member of the Board appointed: Robert J. Spiegel, M.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- Executive departure
COO departs: Timothy Keutzer
Timothy Keutzer, Chief Operating Officer of Spero Therapeutics, Inc., retires the role, effective December 31, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 27, 2026Role: Chief Operating Officer
Only one public record so far. We add events as soon as a new filing lands; watch Spero Therapeutics, Inc. to get them in your digest.
Last verified Nov 8, 2026